Insights into glucocorticoid-associated hypertension

American Journal of Kidney Diseases

Volumn 37, Issue 1, 2001, Pages 1-10

  Brem, A S ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

11 hydroxysteroid dehydrogenase (11 HSD); Glucocorticoids; Hypertension; Renal sodium transport; Vascular smooth muscle

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADENOSINE TRIPHOSPHATASE; ANGIOTENSIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

BLOOD PRESSURE REGULATION; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HYPERTENSION; KIDNEY DISTAL TUBULE; KIDNEY TUBULE ABSORPTION; PROTEIN EXPRESSION; REVIEW; SODIUM TRANSPORT;

EID: 0035162174     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.20637     Document Type: Article

References (100)

1. The basophil adenomas of the pituitary body and their clinical manifestation
2. Adrenocorticotrophin and steroid-induced hypertension in humans
3. Mechanisms of glucocorticoid-induced hypertension
4. Experimental studies on cortisol-induced hypertension in humans
5. Mechanisms of cortisol-induced hypertension in humans
6. Pressor responsiveness in corticosteroid-induced hypertension in humans
7. Glucocorticoids and hypertension in man
8. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol
9. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess
10. Mineralocorticoid activity of liquorice: 11-Beta-hydroxysteroid dehydrogenase deficiency comes of age
11. Glucocorticoids and blood pressure: A role for the cortisol/cortisone shuttle in the control of vascular tone in man
12. Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess
13. Apparent mineralocorticoid excess: Genotype is correlated with biochemical phenotype
14. Studies on steroid cunjugates: VI. Quantitative paper chromatography of urinary corticosteroids in essential hypertension
15. Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension
16. The syndrome of apparent mineralocorticoid excess: Its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism
17. Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase
18. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization
19. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme
20. A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells
21. +)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney
22. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase
23. A new compound heterozygous mutation in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess
24. Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension
25. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor
26. Localisation of 11 beta-hydroxysteroid dehydrogenase - Tissue-specific protector of the mineralocorticoid receptor
27. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated
28. Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: Toward a redefinition of mineralocorticoid action
29. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess
30. Glucocorticoids modulate vascular reactivity in the rat
31. Aldosterone, salt and cardiac fibrosis
32. Structural remodeling in hypertensive heart disease and the role of hormones
33. Chronic mineralocorticoid excess and cardiovascular remodeling
34. Steroid receptors in the central nervous system. Implications in neurology
35. A molecular framework for the actions of glucocorticoid hormones in the nervous system
36. Adrenocortical steroids and the brain
37. Intracerebroventricular infusion of aldosterone induces hypertension in rats
38. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension
39. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension
40. Effect of central amiloride infusion on mineralocorticoid hypertension
41. Corticosteroid receptors and the central nervous system
42. 11 Beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: Localization in hypothalamus, hippocampus, and cortex
43. Hybridization histochemical localization of 11 beta-hydroxysteroid dehydrogenase type 2 in rat brain
44. Mechanism of the glucocorticoid-induced increase in glomerular filtration rate
45. Glucocorticoid-induced renal vasodilation is mediated by a direct renal action involving nitric oxide
46. Glucocorticoids and control of glomerular filtration rate
47. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation
48. Absence of mineralocorticoid-dependent sodium reabsorption in dog proximal tubule
49. Receptors of steroid hormones in the kidney
50. Effect of glucocorticoids on renal cortical NHE-3 and NHE-1 mRNA
51. Role of glucocorticoids in the maturation of renal cortical Na+/H+ exchanger activity during fetal life in sleep
52. Glucocorticoid upregulates Na-K-ATPase α- and β-mRNA via an indirect mechanism in proximal tubule cell primary cultures
53. Regulation of renal Na-HCO3 cotransporter: III. Presence and modulation by glucocorticoids in primary cultures of the proximal tubule
54. Glucocorticoid metabolism in proximal tubules modulates angiotensin II-induced electrolyte transport
55. Influence of dietary sodium on the renal isoforms of 11 beta-hydroxysteroid dehydrogenase
56. Expression of 11 beta-OHSD along the nephron of mammals and humans
57. Multiple patterns of 11 beta-hydroxysteroid dehydrogenase catalytic activity along the mammalian nephron
58. Developmental changes in rat renal 11 beta-hydroxysteroid dehydrogenase
59. Identification of four types of steroid by their interaction with mineralocorticoid receptors in the toad bladder
60. Activity of 11 beta-hydroxysteroid dehydrogenase in toad bladder: Effects of 11-dehydrocorticosterone
61. Cellular responses to steroids in the enhancement of Na+ transport by rat collecting duct cells in culture. Differences between glucocorticoid and mineralocorticoid hormones
62. Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells
63. + permeability of toad urinary bladder
64. The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone
65. 11 beta-hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone
66. Protective and specificity-conferring mechanisms of mineralocorticoid action
67. 11 Alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat
68. Steroid metabolism determines mineralocorticoid specificity in the toad bladder
69. Effect of carbenoxolone on glucocorticoid metabolism and Na transport in toad bladder
70. The role of vascular steroid receptors in the control of vascular contractility and peripheral vascular resistance
71. Colocalization of 11 beta-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells
72. Corticosterone metabolism and effects on angiotensin II receptors in vascular smooth muscle
73. Effects of licorice derivatives on vascular smooth muscle function
74. Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells
75. Glucocorticoids regulate V1a vasopressin receptor expression by increasing mRNA stability in vascular smooth muscle cells
76. Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells
77. Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle contractility
78. + channels
79. Regulation of sodium-calcium exchanger by glucocorticoids and growth factors in vascular smooth muscle
80. + antiport: A unifying factor for essential hypertension
81. Sodium ions, calcium ions, blood pressure regulation and hypertension: A reassessment and hypothesis
82. + channels in hypertension
83. Glucocorticoids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle
84. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
85. Glucocorticoids and atrial natriuretic factor receptors on vascular smooth muscle
86. 2 and glucocorticoid-induced rise in arterial pressure in the rat
87. 11 BetaOH-progesterone affects vascular glucocorticoid metabolism and contractile response
88. Angiotensin II and dexamethasone regulate angiotensinogen mRNA by different mechanisms
89. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle
90. Bidirectional activity of 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle cells
91. Localization of 2 11beta-OH steroid dehydrogenase isoforms in aortic endothelial cells
92. 11 Beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension
93. Glucocorticoid exposure in utero: New model for adult hypertension
94. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep
95. Fetal and placental size and risk of hypertension in adult life
96. Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension
97. Low-birth-weight hypertension via enzyme and receptor imprintings of glucocorticoid
98. Elevated plasma cortisol concentrations: A link between low birth weight and the insulin resistance syndrome?
99. Maternal and fetal influences on blood pressure
100. The differential effect of aldosterone and dexamethasone on pressor responses in adrenalectomized rats